INVESTOR ALERT: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Filed Against Inovio Pharmaceuticals, Inc. (INO) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (Inovio or the Company) (NASDAQ: INO) on behalf of investors who purchased shares of the Companys stock between February 14, 2020 and March 9, 2020, inclusive (the Class Period).

Inovio investors who suffered investment losses in excess of $100,000 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 “ 1585 or (888) 715 “ 1740, or online at http://kaskelalaw.com/case/inovio/, for additional information about this action and their legal rights and options.

The shareholder class action lawsuit alleges that Inovio made a series of misleading statements to investors about the Companys development of a purported vaccine for the novel coronavirus, which artificially inflated the value of the Companys shares during the Class Period and resulted in significant investor losses.

IMPORTANT DEADLINE: Investors who purchased shares of Inovios stock during the Class Period may, no later than May 12, 2020, seek to be appointed as a lead plaintiff representative in the action.

For additional information about this action please contact Kaskela Law LLC. Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about the firm please visit www.kaskelalaw.com.

D. Seamus Kaskela, Esq.

KASKELA LAW LLC

18 Campus Boulevard, Suite 100

Newtown Square, PA 19073

(484) 258 – 1585

(888) 715 – 1740

www.kaskelalaw.com

[email protected]